Investigating opioid prescriptions after hip arthroscopy
Randomized Control Trial Evaluating Postoperative Opioid Demands Following Hip Arthroscopy
This study is testing if giving fewer pain pills after hip surgery can still help patients manage their pain while using less medication.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 170 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Rush University Medical Center Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT04094701 on ClinicalTrials.gov |
What this trial studies
This clinical trial is a prospective, single-blinded, randomized controlled trial that examines the impact of different opioid prescription amounts following primary hip arthroscopy. Participants will be randomly assigned to receive either a reduced opioid regimen of 5 Norco pills along with gabapentin and Tylenol or the standard regimen of 30 Norco pills. The study will track postoperative pain scores, total morphine equivalents used, and patient-reported outcomes over a 12-month follow-up period. The goal is to determine if a reduced opioid prescription can effectively manage pain while minimizing opioid use.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-80 who are opioid naive and undergoing primary hip arthroscopy.
Not a fit: Patients with a history of opioid use, chronic pain conditions, or other significant health issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to safer postoperative pain management strategies that reduce reliance on opioids.
How similar studies have performed: Other studies have shown promising results with reduced opioid prescribing strategies, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients age 18-80 years * English speaking * Opioid naive patient (defined as not taking opioid pills within 6 weeks prior to surgery), confirmed by checking the Illinois Prescription monitoring program * Primary hip arthroscopy * Written and informed consent for study participation Exclusion Criteria: * Minors (\<18 years of age) * Opioid tolerant patients * Revision surgery * Prior infections of the operative joint * History of active malignancy within the past 5 years * Chronic pain conditions including low back pain, chronic pain syndrome, fibromyalgia * History of alcohol or other substance use disorder * Other disease states including rheumatologic conditions, diabetes mellitus, hypo/hyperthyroidism, depression, anxiety * Grade IV chondral defects
Where this trial is running
Chicago, Illinois
- Rush University Medical Center — Chicago, Illinois, United States (Recruiting)
Study contacts
- Study coordinator: Carla M. Edwards
- Email: carla_edwards@rush.edu
- Phone: 312-563-5735
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.